Skip to content
Disclosery

EXANE DERIVATIVES: DE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 530 DE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 530 shares
    Change vs previous 13F -2,582 shares

    0.09% of the 13F portfolio, value $158,702.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,112 shares
    Change vs previous 13F +794 shares

    0.36% of the 13F portfolio, value $1,292,938.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,318 shares
    Change vs previous 13F -784 shares

    0.19% of the 13F portfolio, value $794,856.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,102 shares
    Change vs previous 13F +1,170 shares

    0.26% of the 13F portfolio, value $1,039,435.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,932 shares
    Change vs previous 13F +197 shares

    0.16% of the 13F portfolio, value $677,706.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,735 shares
    Change vs previous 13F -375 shares

    0.2% of the 13F portfolio, value $649,168.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,110 shares
    Change vs previous 13F +2,107 shares

    0.17% of the 13F portfolio, value $567,725.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 3 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $665.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).